Valneva SE Pref. Stock Euronext Paris
Stocks
VLAP
FR0011472943
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| Market Cap | 416M 474M 387M 356M 667M 45.25B 679M 4.59B 1.8B 22.44B 1.78B 1.74B 77.54B | P/E 2026 * |
-5.97x | P/E 2027 * | 5.77x |
|---|---|---|---|---|---|
| Enterprise Value | 544M 620M 506M 466M 873M 59.19B 888M 6.01B 2.35B 29.35B 2.33B 2.28B 101B | EV / Sales 2026 * |
3.58x | EV / Sales 2027 * | 1.62x |
| Free-Float |
97.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Valneva SE Pref.
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 2021-07-28 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 2023-12-19 | |
James Sulat
BRD | Director/Board Member | 75 | 2013-03-06 |
| Chairman | 65 | 2023-12-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 465M | |
| +0.14% | -0.67% | -0.88% | +11.02% | 47.74B | |
| -2.24% | +0.31% | +393.45% | +615.13% | 39.98B | |
| +1.40% | +3.69% | +12.21% | +46.79% | 36.23B | |
| +13.94% | +20.49% | +22.85% | +7.42% | 35.59B | |
| -0.73% | +2.78% | +4.65% | +41.16% | 27.91B | |
| +0.40% | -0.30% | - | - | 16.71B | |
| -3.12% | +7.39% | +26.03% | +124.08% | 16.45B | |
| +2.39% | -1.64% | +4.74% | +9.95% | 13.21B | |
| +6.79% | +8.17% | -4.97% | -28.52% | 12.93B | |
| Average | +1.90% | +2.78% | +57.26% | +103.38% | 27.42B | |
| Weighted average by Cap. | +2.10% | +2.95% | +76.07% | +130.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 152M 173M 141M 130M 244M 16.53B 248M 1.68B 656M 8.2B 649M 635M 28.32B | 294M 335M 274M 252M 472M 32.01B 480M 3.25B 1.27B 15.87B 1.26B 1.23B 54.85B |
| Net income | -66.01M -75.22M -61.47M -56.54M -106M -7.19B -108M -729M -285M -3.56B -282M -276M -12.31B | 70.5M 80.33M 65.65M 60.38M 113M 7.67B 115M 779M 305M 3.81B 302M 295M 13.15B |
| Net Debt | 128M 146M 119M 110M 206M 13.94B 209M 1.41B 554M 6.91B 548M 536M 23.88B | 60.02M 68.39M 55.89M 51.4M 96.36M 6.53B 98.01M 663M 260M 3.24B 257M 251M 11.19B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- VLAP Stock
Select your edition
All financial news and data tailored to specific country editions
